GENERAL ATLANTIC, L.P. - Q3 2023 holdings

$6.48 Billion is the total value of GENERAL ATLANTIC, L.P.'s 29 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 3.3% .

 Value Shares↓ Weighting
 ENGAGESMART$1,623,985,005
-5.8%
90,271,5400.0%25.07%
-7.7%
DLO  DLOCALcl a$1,225,091,343
+57.1%
63,906,6950.0%18.91%
+53.8%
XP  XP, INCcl a$682,688,746
-1.7%
29,617,7330.0%10.54%
-3.8%
SQSP SellSQUARESPACEcl a$481,222,785
-31.8%
16,611,073
-25.7%
7.43%
-33.2%
ALHC  ALIGNMENT HEALTHCARE$423,293,662
+20.7%
60,993,3230.0%6.53%
+18.2%
ALKT  ALKAMI$341,257,065
+11.2%
18,729,8060.0%5.27%
+8.9%
 HIRERIGHT$305,365,130
-15.9%
32,109,8980.0%4.71%
-17.7%
 EUROPEAN WAX CENTERcl a$212,389,970
-13.0%
13,110,4920.0%3.28%
-14.9%
 MOBILEYEcl a$197,857,153
+8.1%
4,761,9050.0%3.05%
+5.9%
KRTX BuyKARUNA THERAPEUTICS$166,842,794
+5.8%
986,710
+35.7%
2.58%
+3.6%
 DUOLINGOcl a$96,311,089
+16.0%
580,6420.0%1.49%
+13.7%
PHVS  PHARVARIS$91,958,479
+37.8%
4,406,2520.0%1.42%
+35.0%
AKRO  AKERO THERAPEUTICS$90,321,414
+8.3%
1,785,7140.0%1.39%
+6.1%
YOU SellCLEAR SECUREcl a$75,730,496
-32.8%
3,977,442
-18.2%
1.17%
-34.1%
HCM  HUTCHMEDsponsored ads$67,760,000
+41.2%
4,000,0000.0%1.05%
+38.2%
FUTU SellFUTUspon ads cl a$64,014,574
+44.9%
1,107,327
-0.4%
0.99%
+42.0%
CNTA  CENTESSA PHARMACEUTICALSsponsored ads$62,641,362
+4.5%
9,681,8180.0%0.97%
+2.3%
ARCE  ARCO PLATFORM LIMITEDcl a$56,544,383
+13.5%
4,103,3660.0%0.87%
+11.2%
IMCR  IMMUNOCOREads$49,305,000
-13.4%
950,0000.0%0.76%
-15.3%
RPRX  ROYALTY PHARMA$40,710,000
-11.7%
1,500,0000.0%0.63%
-13.6%
BuyACELYRIN$29,387,924
-6.3%
2,889,668
+92.6%
0.45%
-8.1%
 BLEND LABScl a$26,211,443
+44.6%
19,132,4400.0%0.40%
+41.6%
 RISKIFIEDcl a$23,855,991
-7.8%
5,324,9980.0%0.37%
-9.8%
 THIRD HARMONIC BIO$18,906,489
+32.8%
2,958,7620.0%0.29%
+30.4%
OPEN  OPENDOOR$16,688,810
-34.3%
6,321,5190.0%0.26%
-35.7%
 BUZZFEEDcl a$3,004,262
-24.3%
7,862,5020.0%0.05%
-27.0%
 WISHcl a new$2,688,402
-33.0%
609,6150.0%0.04%
-34.9%
 GROVE COLLABORATIVEcl a$2,489,813
+50.3%
936,0200.0%0.04%
+46.2%
ADAG  ADAGENEads$403,920
+3.4%
264,0000.0%0.01%0.0%
ExitGINKGO BIOWORKScl a$0-32,319,896
-100.0%
-0.95%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
XP, INC16Q3 202378.5%
ENGILITY HOLDINGS INC16Q4 201825.0%
CHINA INDEX HOLDINGS16Q1 20232.0%
58.COM INC15Q2 202039.3%
ARCO PLATFORM LTD15Q3 202332.7%
ROYALTY PHARMA14Q3 20232.2%
KCG HOLDINGS INC13Q3 201621.8%
FANG HOLDINGS13Q3 201913.8%
BAZAARVOICE INC13Q2 20162.8%
TRINET GROUP INC12Q4 201641.1%

View GENERAL ATLANTIC, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)
GENERAL ATLANTIC, L.P. Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Fang Holdings LtdSeptember 25, 202311,106,44016.8%
XP Inc.July 11, 202329,617,7337.1%
Oak Street Health, Inc.Sold outMay 02, 202300.0%
dLocal LtdApril 25, 202363,096,50138.9%
China Index Holdings LtdSold outApril 19, 202300.0%
CinCor Pharma, Inc.Sold outFebruary 28, 202300.0%
Alignment Healthcare, Inc.February 13, 202360,993,32332.6%
Duolingo, Inc.February 13, 20231,479,2944.7%
European Wax Center, Inc.February 13, 202322,817,20141.5%
Ginkgo Bioworks Holdings, Inc.February 13, 202332,319,8962.4%

View GENERAL ATLANTIC, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
42024-03-15
SC 13G2024-03-15
SC 13D/A2024-03-07
SC 13D/A2024-02-16
13F-HR2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View GENERAL ATLANTIC, L.P.'s complete filings history.

Compare quarters

Export GENERAL ATLANTIC, L.P.'s holdings